Ameritas Investment Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,824
| Closed | -$448K | – | 3105 |
|
|
2021
Q4 | $448K | Buy |
4,824
+95
| +2% | +$6.26K | 0.02% | 836 |
|
|
2021
Q3 | $282K | Hold |
4,729
| – | – | 0.01% | 996 |
|
|
2021
Q2 | $323K | Hold |
4,729
| – | – | 0.01% | 929 |
|
|
2021
Q1 | $328K | Sell |
4,729
-141
| -3% | -$10.8K | 0.01% | 914 |
|
|
2020
Q4 | $374K | Sell |
4,870
-35
| -0.7% | -$2.62K | 0.02% | 852 |
|
|
2020
Q3 | $367K | Hold |
4,905
| – | – | 0.02% | 806 |
|
|
2020
Q2 | $309K | Buy |
4,905
+380
| +8% | +$20.9K | 0.01% | 848 |
|
|
2020
Q1 | $190K | Buy |
4,525
+136
| +3% | +$6.24K | 0.01% | 963 |
|
|
2019
Q4 | $199K | Buy |
4,389
+250
| +6% | +$11.8K | 0.01% | 1089 |
|
|
2019
Q3 | $189K | Hold |
4,139
| – | – | 0.01% | 1083 |
|
|
2019
Q2 | $243K | Hold |
4,139
| – | – | 0.01% | 969 |
|
|
2019
Q1 | $186K | Hold |
4,139
| – | – | 0.01% | 1093 |
|
|
2018
Q4 | $161K | Hold |
4,139
| – | – | 0.01% | 1083 |
|
|
2018
Q3 | $190K | Hold |
4,139
| – | – | 0.01% | 1115 |
|
|
2018
Q2 | $180K | Buy |
4,139
+59
| +1% | +$2.54K | 0.01% | 1127 |
|
|
2018
Q1 | $161K | Buy |
4,080
+730
| +22% | +$28.4K | 0.01% | 1196 |
|
|
2017
Q4 | $114K | Buy |
3,350
+762
| +29% | +$21.7K | 0.01% | 1437 |
|
|
2017
Q3 | $59K | Hold |
2,588
| – | – | ﹤0.01% | 1785 |
|
|
2017
Q2 | $44K | Buy |
2,588
+620
| +32% | +$8.5K | ﹤0.01% | 1996 |
|
|
2017
Q1 | $29K | Hold |
1,968
| – | – | ﹤0.01% | 2186 |
|
|
2016
Q4 | $28K | Hold |
1,968
| – | – | ﹤0.01% | 1148 |
|
|
2016
Q3 | $34K | Hold |
1,968
| – | – | ﹤0.01% | 1129 |
|
|
2016
Q2 | $34K | Hold |
1,968
| – | – | ﹤0.01% | 1059 |
|
|
2016
Q1 | $39K | Hold |
1,968
| – | – | ﹤0.01% | 1042 |
|
|
2015
Q4 | $37K | Hold |
1,968
| – | – | ﹤0.01% | 1040 |
|
|
2015
Q3 | $38K | Hold |
1,968
| – | – | ﹤0.01% | 1013 |
|
|
2015
Q2 | $91K | Hold |
1,968
| – | – | 0.01% | 1023 |
|
|
2015
Q1 | $86K | Hold |
1,968
| – | – | 0.01% | 1062 |
|
|
2014
Q4 | $68K | Hold |
1,968
| – | – | ﹤0.01% | 1055 |
|
|
2014
Q3 | $82K | Hold |
1,968
| – | – | 0.01% | 1016 |
|
|
2014
Q2 | $115K | Buy |
1,968
+90
| +5% | +$5.67K | 0.01% | 1034 |
|
|
2014
Q1 | $118K | Hold |
1,878
| – | – | 0.01% | 1011 |
|
|
2013
Q4 | $110K | Hold |
1,878
| – | – | 0.01% | 1005 |
|
|
2013
Q3 | $99K | Buy |
+1,878
| New | +$126K | 0.01% | 954 |
|
Ameritas Investment Partners's ARNA Position: Q1 2022 in Review
Ameritas Investment Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,824 shares — an estimated $448K sold.
Ameritas Investment Partners first reported a position in ARNA in Q3 2013 and held it in 34 quarters. The position peaked at $448K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Ameritas Investment Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Ameritas Investment Partners sold 4,824 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $448K.
- Ameritas Investment Partners first reported a position in Arena Pharmaceuticals Inc in Q3 2013 and held it in 34 quarters.
- Ameritas Investment Partners's Arena Pharmaceuticals Inc position peaked at $448K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Ameritas Investment Partners's 13F filing for Q1 2022, filed 13 May 2022.